Employees Retirement System of Texas’s Moderna MRNA Stock Holding History

Employees Retirement System of Texas’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.68M	Hold	38,329	–	–	0.02%	170
2026 Q1	$1.95M	Hold	38,329	–	–	0.02%	177
2025 Q4	$1.13M	Hold	38,329	–	–	0.01%	241
2025 Q3	$990K	Hold	38,329	–	–	0.01%	240
2025 Q2	$1.06M	Hold	38,329	–	–	0.01%	277
2025 Q1	$1.09M	Hold	38,329	–	–	0.01%	223
2024 Q4	$1.59M	Hold	38,329	–	–	0.01%	252
2024 Q3	$2.56M	Buy	38,329 +1,840	+5%	+$169K	0.02%	232
2024 Q2	$4.33M	Buy	36,489 +973	+3%	+$123K	0.04%	160
2024 Q1	$3.79M	Buy	35,516 +18,787	+112%	+$1.89M	0.04%	180
2023 Q4	$1.66M	Buy	+16,729	New	+$1.41M	0.02%	248
2022 Q3	–	Sell	-48,000	Closed	-$6.86M	–	564
2022 Q2	$6.86M	Hold	48,000	–	–	0.1%	247
2022 Q1	$8.27M	Hold	48,000	–	–	0.1%	238
2021 Q4	$12.2M	Hold	48,000	–	–	0.14%	190
2021 Q3	$18.5M	Hold	48,000	–	–	0.22%	121
2021 Q2	$11.3M	Buy	+48,000	New	+$8.58M	0.14%	191
2021 Q1	–	Sell	-30,000	Closed	-$3.13M	–	754
2020 Q4	$3.13M	Sell	30,000 -7,000	-19%	-$708K	0.05%	385
2020 Q3	$2.62M	Hold	37,000	–	–	0.04%	425
2020 Q2	$2.38M	Buy	+37,000	New	+$2.03M	0.04%	440

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Employees Retirement System of Texas's MRNA Position: Q2 2026 in Review

Employees Retirement System of Texas held its Moderna (MRNA) position steady in Q2 2026 at 38,329 shares worth $2.68M. The position accounts for 0.02% of the portfolio, ranked #170.

Employees Retirement System of Texas first reported a position in MRNA in Q2 2020 and has held it in 19 quarters since. The position peaked at $18.5M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Employees Retirement System of Texas held 38,329 shares of Moderna worth $2.68M as of Q2 2026.
Employees Retirement System of Texas left its Moderna share count unchanged in Q2 2026.
Moderna made up 0.02% of Employees Retirement System of Texas's portfolio in Q2 2026, its #170 holding.
Employees Retirement System of Texas first reported a position in Moderna in Q2 2020 and has held it in 19 quarters since.
Employees Retirement System of Texas's Moderna position peaked at $18.5M in Q3 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.